PTAB challenges

Proceedings overview

One AIA trial proceeding is on file for US7577417, which is currently active with a "Trial Instituted" status. This proceeding directly challenges claims 1-7 of the patent, presenting a significant defensive opportunity for any defendant facing assertion of this patent.

IPR2025-01309 — [[[Samsung Electronics Co.](/litigations/by-defendant/Samsung%20Electronics%20Co.), Ltd.](/litigations/by-plaintiff/Samsung%20Electronics%20Co.%2C%20Ltd.) et al.](/litigations/by-plaintiff/Samsung%20Electronics%20Co.%2C%20Ltd.%20et%20al.) v. Maxell, LTD.

• Type: Inter Partes Review
• Filed: 2025-08-27
• Status: Trial Instituted. The PTAB has granted institution, meaning the trial is currently underway.
• Judge panel: A three-member PTAB panel would be assigned to conduct the trial following the Director's institution decision. The specific panel members are not publicly available in the provided search results at this stage.
• Petition grounds: Samsung Electronics Co., Ltd. et al. challenged claims 1-7 of US7577417, likely under 35 U.S.C. §§ 102 (anticipation) and/or 103 (obviousness), referencing prior art including U.S. Patent No. 5,303,171 ("Belt"), U.S. Patent No. 6,223,293 ("Foster"), U.S. Patent No. 5,630,148 ("Norris"), and U.S. Patent No. 6,094,565 ("Alberth").
• Institution decision: Instituted on 2026-02-09. Despite arguments from Patent Owner Maxell against institution, the Board (or Director, as institution decisions after October 2025 are made by the Director in consultation with PTAB judges) determined that the petitioner had demonstrated a reasonable likelihood of prevailing on at least one challenged claim.
• Final Written Decision (if issued): Not yet issued. The statutory deadline for the Final Written Decision is typically one year from the institution date, placing it around 2027-02-09.
• Settlement / termination: No information found indicating settlement or termination.
• Appeal: Not applicable yet, as no Final Written Decision has been issued.
• Defensive value: This active IPR means that the patentability of all seven claims of US7577417 is currently under review by the PTAB. A defendant facing assertion of this patent should closely monitor this proceeding, as an invalidation of any of these claims would significantly weaken the patent owner's case.

Strategic summary

As of today, 2026-05-22, claims 1-7 of US7577417 are currently UNTESTED by a Final Written Decision from the PTAB. There is an active Inter Partes Review, IPR2025-01309, which has been instituted against all claims of the patent. Therefore, no claims have been definitively canceled or sustained by the PTAB yet.

The estoppel landscape for IPR2025-01309 will only be established upon the issuance of a Final Written Decision. If claims are found unpatentable, 35 U.S.C. § 315(e)(2) would prevent Samsung Electronics Co., Ltd. (and its privies) from asserting in other proceedings any invalidity ground under §§ 102 or 103 that they raised or reasonably could have raised during the IPR. Conversely, if claims are found patentable, Maxell, LTD. would benefit from those claims being hardened against the same or substantially similar arguments by Samsung and its privies.

There are no indications of other IPRs filed against this patent, nor a pattern of aggressive PTAB appeals by the patent owner. The petitioner, Samsung Electronics Co., Ltd., is a named corporate entity, not a defensive aggregator like Unified Patents.

Recommended next steps

Given that IPR2025-01309 is ongoing and trial has been instituted, a defendant involved in litigation concerning US7577417 should take the following steps:

• Monitor IPR2025-01309 Closely: Continuously track the progress of IPR2025-01309 for all trial-stage milestones, including Patent Owner Response, Petitioner Reply, potential oral hearings, and critically, the issuance of the Final Written Decision (due around 2027-02-09).
• Review Institution Decision: Obtain and thoroughly analyze the Institution Decision (Paper 11 from IPR2025-01309, dated 2026-02-09) from the USPTO PTAB E2E portal. This document will detail the specific prior art and reasoning that the PTAB found compelling enough to institute the trial against claims 1-7, providing insights into potential invalidity arguments.
• Consider a Litigation Stay: If litigation involving US7577417 is active, evaluate the strategic benefit of requesting a stay of the district court proceedings. A favorable outcome in the IPR (i.e., invalidation of claims 1-7) could significantly narrow or eliminate the basis for the ongoing litigation.